X
20
Fresenius Kabi Oncology Limited Kalyani In, based in India, is a pharmaceutical company that stands out with its certifications from WHO-GMP.
One of their significant offerings is Letrozole, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2007-338 - Rev 03
This Chemical Type CEP, issued on January 09, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2334 associated with this CEP further emphasizes